Markets Brace as WHO Declares Latest Ebola Outbreak
The WHO has declared the latest ebola outbreak a public health emergency of international concern, prompting a wave o...
Choosing the best Dividend Aristocrats Etf for retirees involves yield, cost, and risk assessment. This intro guides the evaluation process.
22,751 articlesThe WHO has declared the latest ebola outbreak a public health emergency of international concern, prompting a wave o...
Standard Chartered is moving to absorb Zodia Custody's crypto operations, extending its digital-asset platform. The d...
A high-flying biotech spin-off has faced a brutal disconnect between hype and reality. This beaten-down growth stock ...
When a hedge fund makes a substantive move in Genpact, it prompts investors to reassess the stock. This article break...
AI-driven capital spending is accelerating demand for etching and related fabrication equipment, spotlighting semicon...
Cardano’s May 29 hard fork vote is unfolding as a practical test of governance and DeFi activity. Key infrastructure ...
Investing in early-stage biotech requires a steady playbook. This article breaks down Lantern Pharma (LTRN) in 2025, ...
Is Micron Technology stock on a durable uptrend or chasing a bubble? This guide lays out the signals, scenarios, and ...
Grab is accelerating its push into physical AI and automated driving, testing robots in Singapore and at its own offi...
A major private markets investor recently exited its position in Paymentus Holdings, shedding a sizable stake in a mo...
A $10.2 billion hidden revenue stream from data-center power equipment is quietly driving the AI infrastructure boom....
A new wave of skepticism surrounds the Fed after a high-profile critique from a former governor. This piece explains ...